Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A novel ErbB-4 ligand, referred to herein as Neuregulin-4 (NRG-4) is disclosed as well as polynucleotide sequences encoding NRG-4, oligonucleotides and oligonucleotide analogs derived from polynucleotide sequences, a display library displaying short peptides derived from NRG-4, antibodies recognizing NRG-4, peptides or peptide analogs derived from NRG-4, and pharmaceutical compositions and methods of employing peptides or peptide analogs, oligonucleotides and oligonucleotide analogs, and/or polynucleotide sequences to up-regulate or down-regulate ErbB-4 receptor activity (signaling).

Abstract: The present invention relates to an optical switch comprising a paraelectric photorefractive material, storing a hologram, possibly a latent hologram, whose reconstruction, or activation and reconstruction, is controllable by means of an applied electric field. The hologram may be formed by spatial modulation of the refractive index of the paraelectric photorefractive material, which arises from the quadratic electro-optic effect induced by the combined action of a spatially modulated space charge within the paraelectric photorefractive material and an external applied electric field. The present invention further relates to a switching network, such as a multistage network, for use in an optical communications system, incorporating at least one optical switch according to the invention.

Abstract: A positive acting, composition that can be heat-sensitive is presented, either coated on a lithographic base, or on a printing circuit board base, and comprises a water soluble heat-sensitive resin, a novel adhesion promoter and a radiation absorbing agent—a dye or a pigment. An excellent film forming polymer that comprises acetal units directly pendant from the polymer polyvinyl alcohol backbone may be the only binder resin, when other resins being optional. The solubility of the coated material in the areas exposed to near -IR laser radiation in mild alkaline developers becomes considerably higher, allowing to obtain high resolved patterns of the etch-resistant material on printing circuit boards or lithographic printing plates. The composition can be applied on the substrate from a liquid of laminated as a dry film. Sensitizers may be added to render the composition sensitive to radiation in a non-thermal sense.

Abstract: A portable device for providing an information management system for blind individuals, including those who read Braille format writing, and who may either partially or completely lack sight capabilities, and/or who may be unable to process visual information obtained from printed character materials. The portable device features a scanner for scanning the printed material, software for interpreting and translating the printed material into Braille and a Braille array display for displaying the Braille. In addition, the portable device preferably features an annotation feature for adding notes to the text as well as for separate text entry, more preferably through a Braille keyboard. Other preferred components include an organizer component for providing calendar information, reminders and other useful functions for the management of information.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A variety of heparanase specific molecular probes which can be used for research and medical applications including diagnosis and therapy are disclosed. Specific applications include the use of a heparanase specific molecular probe for detection of the presence, absence or level of heparanase expression; the use of a heparanase specific molecular probe for therapy of a condition associated with expression of heparanase; the use of a heparanase specific molecular probe for quantification of heparanase in a body fluid; the use of a heparanase specific molecular probe for targeted drug delivery; and, the use of a heparanase specific molecular probe as a therapeutic agent.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A contour mapping system useful as a spine analyzer includes a probe for application to a user's hand with the outer tip of at least one finger of the hand movable along the outer surface of the person's spine or other object whose contour is to be mapped. A position sensor carried by the probe is movable with the user's finger as the finger moves along the outer surface of the object. The system tracks and displays the movements of the position sensor as the probe is moved with the user's hand along the outer surface of the object. An ultrasonic transducer may be combined with the position sensor on the same probe and used to examine particular vertebrae, such as apex vertebrae, for rotation and/or deformation.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A system and method including a simulation model with at least one flexible constraint on a data structure. The term “flexible constraint” indicates that the constraint is not limited to any one type of data structures, but instead can be used for any type of data structure. The preferred data structures include an object, a list of objects and a list of scalars. An object includes at least one data element and optionally a function for operating on the data element. The data element in turn could be a scalar or another object, for example. Preferably, the data structure is not a single scalar The method of the present invention determines the constraint which should be applied to data structure, and then applies the constraint during the test generation process.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A suturing instrument includes a jaw and a pivotally mounted puncturer to be located on opposite sides of the tissue to be sutured. The suture is applied while the puncturer is in an open position on one side of the jaw, and the needle is then pivoted to a closed position through an opening in the jaw to pierce the tissue and to bring a portion of the suture to the opposite side of the jaw. At the opposite side of the jaw, a crochet head is actuated to engage the suture and to clamp it to the jaw as the puncturer is pivoted back to its open position.

Abstract: A method and apparatus for providing an indication of the composition of an examined fluid by using an electrical resistor, particularly a positive temperature coefficient thermistor, for measuring the thermal conductivity of the examined fluid with the known thermal conductivity of different fluid compositions. The method and apparatus are particularly described for indicating the relative proportions of a working fluid in the liquid and vapor phases in one or more stages of a heat pump. Another described application is for indicating the liquid level in a liquid vaporizer.

Abstract: A wide angle directed reflector is disclosed. The directed reflector includes a lenticular layer including at least one array of lenslets, each of which having a focal length, The directed reflector further includes a reflective layer which is disposed relative to the lenticular layer. The lenticular layer and the reflective layer are constructed, designed and relatively disposed such that light incident at an angle of incidence on the lenticular layer is reflected by the reflective layer and redirected through the lenticular layer at a substantially constant angle relative to the angle of incidence.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.

Abstract: A miniature piezoelectric transducer element is provided, comprising: (a) a cell element having a cavity; (b) a flexible piezoelectric layer attached to the cell member, the piezoelectric layer having an external surface and an internal surface, the piezoelectric layer featuring such dimensions so as to enable fluctuations thereof at its resonance frequency upon impinging of an external acoustic wave; and (c) a first electrode attached to the external surface and a second electrode attached to the internal surface of the piezoelectric layer. At least one of the electrodes may be specifically shaped so as to provide a maximal electrical output, wherein the electrical output may be current, voltage or power. A preferred shape of the electrodes includes two cores interconnected by a connecting member. The transducer element may function as a transmitter.

Abstract: A contour mapping system useful as a spine analyzer includes a probe for application to a user's hand with the outer tip of at least one finger of the hand movable along the outer surface of the object (e.g., a person's spine) whose contour is to be mapped. A position sensor is carried by the probe and is movable therewith, and with the user's hand, as the user's finger moves along the outer surface of the object. The system further includes a position tracking system for tracking the movement of the position sensor as the probe is moved with the user's hand along the outer surface of the object.

Abstract: The present invention discloses: (i) a non-pathogenic probiotic microorganism and its probiotic/therapeutic uses; (ii) a formulation comprising an aqueous solution of a volatile fraction (VF) prepared from the extract of at least one plant derived material and its therapeutic uses; (iii) a process of manufacturing the formulation from the plant derived material; (iv) a probiotic composition comprising the non-pathogenic probiotic microorganism of the invention and/or other probiotic microorganism(s) and the formulation of the invention, and its probiotic/therapeutic uses; (v) a composition for industrial applications comprising the formulation of the invention and microorganism(s) of industrial applicability; and (vi) industrial processes and apparatuses in which the latter composition is used.